在HCC TME中信号通路重塑和分子调节:动态进化和临床治疗进展
Lin Xu1, Xuanhao Zhang1, Hengzhou Zhu1
1Department of Oncology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, 214071 Wuxi, Jiangsu, China.
本综述详细介绍了肝细胞癌 (HCC) 瘤微环境 (TME) 在疾病进展过程中的变化. 了解这些TME动态和信号通路,可以了解针对HCC的向治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝细胞癌 (HCC) 的进展涉及复杂的瘤微环境 (TME) 和信号通路的改变.
- 慢性肝炎和肝硬化阶段表现出明显的TME特征,影响HCC发展.
研究的目的:
- 审查HCC TME内的分子调节和信号通路改造.
- 描述TME在HCC进展过程中的动态转变.
- 评估针对TME的HCC的治疗策略.
主要方法:
- 主要的HCC TME组件的概况.
- 关键信号通路的分析,包括受体氨酸激酶 (RTK) 和细胞外信号调节激酶 (ERK).
- 从炎症到纤维化转变的TME状态的表征.
主要成果:
- TME和信号通路表现出特定阶段的变化,从肝炎到肝硬化到HCC.
- 受体氨酸激酶 (RTK) 和细胞外信号调节激酶 (ERK) 途径在HCC中至关重要.
- 在肝炎中,TME从炎症状态转变为肝硬化中的纤维状状态.
结论:
- 了解HCC TME动态对于治疗开发至关重要.
- 针对特定的信号通路和TME组件为HCC的精密医学提供了机会.
- 新兴的战略重点是针对肝细胞癌的个性化治疗方法.
更多相关视频
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
相关概念视频
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
